SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the “Company” or “Ligand”) announced today that it would delay filing its quarterly report on Form 10-Q due November 9, 2006 and that it would delay the press release announcing the financial results of the third quarter of fiscal 2006 which ended September 30, 2006.
